Vendor: Marketplace supplier
Product metadata will be available once the catalog entry is complete.
Formulations: - Oral > Solid > tablet: 60 mg (as sulfate) + 5 mg + 30 mg (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus Source: EML workbook import
Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
